Table 5.6b

Immunosuppression Use for Induction by Discharge Regimen, 2000 to 2004

Recipients with Kidney Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac CyA+ MMF Tac+ MMF CyA+ Aza Tac+ Aza Siro+ MMF CyA+ Siro Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 1,342 3,025 17505 33693 965 700 1,869 2,362 4,254 5,019 70734
% of All Regimens 1.9% 4.3% 24.7% 47.6% 1.4% 1.0% 2.6% 3.3% 6.0% 7.1% 100.0%
Induction Drug 1.5% 0.8% 2.4% 1.8% 10.1% 6.0% 2.2% 1.8% 1.1% 3.0% 2.1%
Atgam/NRATG/NRATS
OKT3 0.5% 0.5% 0.7% 0.9% 0.7% 0.1% 0.4% 0.5% 0.7% 1.4% 0.8%
Thymoglobulin 12.7% 21.3% 15.3% 29.4% 18.2% 25.0% 30.4% 25.9% 32.2% 38.0% 25.7%
Zenapax 7.4% 4.8% 16.6% 13.8% 5.6% 12.7% 16.1% 3.0% 7.1% 13.2% 13.1%
Simulect 19.1% 16.6% 29.9% 20.5% 32.2% 27.6% 32.3% 22.8% 22.6% 31.5% 24.2%
Campath 0.2% 7.5% 1.4% 2.2% 0.0% 0.1% 1.5% 0.0% 0.3% 6.4% 2.3%
No Induction Drugs Recorded 59.8% 50.0% 35.5% 34.9% 34.2% 29.0% 21.4% 47.5% 38.6% 35.1% 36.4%


Source: OPTN/SRTR Data as of May 2, 2005.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.